_id
691482f6ccc777a4e85d940d
Ticker
NNNN
Name
Anbio Biotechnology Class A Ordinary Shares
Exchange
NASDAQ
Address
Wilhelm Gutbrod Str 21B, Frankfurt am Main, Germany, 60437
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.anbio.com
Description
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Last Close
28.7
Volume
22298
Current Price
34.99
Change
-0.59
Last Updated
2026-01-05T11:32:42.466Z
Image
data:image/webp;base64,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
Ipo Date
2025-02-19T00:00:00.000Z
Market Cap
1293912576
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
-
Target Price
-
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2025-06-30
Revenue
5007271
Cost Of Revenue
384382
Gross Profit
4622889
Operating Expenses
945209
Operating Income
3677680
Interest Expense
-
Pretax Income
4148014
Net Income
4148014
Eps
0.09450673483522894
Dividends Per Share
-
Shares Outstanding
43891200
Income Tax Expense
-
EBITDA
4148010
Operating Margin
73.44679367264123
Total Other Income Expense Net
470333
Cash
6278324
Short Term Investments
9485297
Receivables
4362471
Inventories
-
Total Current Assets
32492865
Property Plant Equipment
-
Total Assets
32492865
Payables
70841
Short Term Debt
-
Long Term Debt
-
Total Liabilities
153923
Equity
32338941
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
491.3333
PB
47.4892819774154
ROE
12.826684708073774
ROA
12.765922611010142
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
69
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
9.5
Garp Investing Score
5
Growth Investing Score
3
Momentum Investing Score
8
Net Net Investing Score
2.5
Quality Investing Score
7
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
5007271
Quarters > 0 > income Statement > cost Of Revenue
384382
Quarters > 0 > income Statement > gross Profit
4622889
Quarters > 0 > income Statement > operating Expenses
945209
Quarters > 0 > income Statement > operating Income
3677680
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
4148014
Quarters > 0 > income Statement > net Income
4148014
Quarters > 0 > income Statement > eps
0.09450673483522894
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
43891200
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
4148010
Quarters > 0 > income Statement > operating Margin
73.44679367264123
Quarters > 0 > income Statement > total Other Income Expense Net
470333
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
6278324
Quarters > 0 > balance Sheet > short Term Investments
9485297
Quarters > 0 > balance Sheet > receivables
4362471
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
32492865
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
32492865
Quarters > 0 > balance Sheet > payables
70841
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
153923
Quarters > 0 > balance Sheet > equity
32338941
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.09450673483522894
Quarters > 0 > ratios > PB
47.4892819774154
Quarters > 0 > ratios > ROE
12.826684708073774
Quarters > 0 > ratios > ROA
12.765922611010142
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
69
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2528206
Quarters > 1 > income Statement > cost Of Revenue
390512
Quarters > 1 > income Statement > gross Profit
2137693
Quarters > 1 > income Statement > operating Expenses
3872949
Quarters > 1 > income Statement > operating Income
-1735255
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1324772
Quarters > 1 > income Statement > net Income
-1324772
Quarters > 1 > income Statement > eps
-0.031325003783292976
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
42291200
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1324776
Quarters > 1 > income Statement > operating Margin
-68.63582318845853
Quarters > 1 > income Statement > total Other Income Expense Net
410483
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
11760859
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1064794
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
18534344
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
18921784
Quarters > 1 > balance Sheet > payables
1625255
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1730234
Quarters > 1 > balance Sheet > equity
17191550
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1324772
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
3138905
Quarters > 1 > cash Flow > cash From Operations
1604491
Quarters > 1 > cash Flow > capital Expenditures
1.67
Quarters > 1 > cash Flow > cash From Investing
215569
Quarters > 1 > cash Flow > cash From Financing
-248893
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.031325003783292976
Quarters > 1 > ratios > PB
86.07537354107106
Quarters > 1 > ratios > ROE
-7.705948561938859
Quarters > 1 > ratios > ROA
-7.001306007932444
Quarters > 1 > ratios > FCF
1604489.33
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.6346355202068186
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
6322620
Quarters > 2 > income Statement > cost Of Revenue
2095797
Quarters > 2 > income Statement > gross Profit
4226823
Quarters > 2 > income Statement > operating Expenses
337502
Quarters > 2 > income Statement > operating Income
3889321
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
3887460
Quarters > 2 > income Statement > net Income
3887460
Quarters > 2 > income Statement > eps
0.09192125075665859
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
42291200
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
3887461
Quarters > 2 > income Statement > operating Margin
61.514388022686795
Quarters > 2 > income Statement > total Other Income Expense Net
-1861.24
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
10310390
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4615109
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
18766112
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
18943105
Quarters > 2 > balance Sheet > payables
478960
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
527753
Quarters > 2 > balance Sheet > equity
18415352
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
3887460
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-3090576
Quarters > 2 > cash Flow > cash From Operations
647539
Quarters > 2 > cash Flow > capital Expenditures
0.31
Quarters > 2 > cash Flow > cash From Investing
149344
Quarters > 2 > cash Flow > cash From Financing
-124142
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.09192125075665859
Quarters > 2 > ratios > PB
80.35518886633282
Quarters > 2 > ratios > ROE
21.109887011662877
Quarters > 2 > ratios > ROA
20.52176768275317
Quarters > 2 > ratios > FCF
647538.69
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.1024161961338812
Quarters > 2 > health Score
76
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
3950600
Quarters > 3 > income Statement > cost Of Revenue
2259079
Quarters > 3 > income Statement > gross Profit
1691521
Quarters > 3 > income Statement > operating Expenses
1107780
Quarters > 3 > income Statement > operating Income
583740
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
792932
Quarters > 3 > income Statement > net Income
792932
Quarters > 3 > income Statement > eps
0.018749337923728814
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
42291200
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
796474
Quarters > 3 > income Statement > operating Margin
14.775983394927353
Quarters > 3 > income Statement > total Other Income Expense Net
209191
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
9687976
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
1884960
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
15749631
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
15811768
Quarters > 3 > balance Sheet > payables
827151
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
993060
Quarters > 3 > balance Sheet > equity
14818708
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
792932
Quarters > 3 > cash Flow > depreciation
3540.21
Quarters > 3 > cash Flow > change In Working Capital
-1970657
Quarters > 3 > cash Flow > cash From Operations
-1331619
Quarters > 3 > cash Flow > capital Expenditures
0.84
Quarters > 3 > cash Flow > cash From Investing
160696
Quarters > 3 > cash Flow > cash From Financing
230082
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.018749337923728814
Quarters > 3 > ratios > PB
99.85817171105606
Quarters > 3 > ratios > ROE
5.350884840972641
Quarters > 3 > ratios > ROA
5.01482187191211
Quarters > 3 > ratios > FCF
-1331619.84
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.3370677466713917
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8185146
Annuals > 0 > income Statement > cost Of Revenue
2299762
Annuals > 0 > income Statement > gross Profit
5885384
Annuals > 0 > income Statement > operating Expenses
3890017
Annuals > 0 > income Statement > operating Income
1995367
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
2372842
Annuals > 0 > income Statement > net Income
2372842
Annuals > 0 > income Statement > eps
0.05610722532785897
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
42291202
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
2566682
Annuals > 0 > income Statement > operating Margin
24.377903582904935
Annuals > 0 > income Statement > total Other Income Expense Net
377475
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
11760859
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1064794
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
18534344
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
18921784
Annuals > 0 > balance Sheet > payables
1625255
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1730234
Annuals > 0 > balance Sheet > equity
17191550
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2372842
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
44646
Annuals > 0 > cash Flow > cash From Operations
2080387
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
337101
Annuals > 0 > cash Flow > cash From Financing
-344605
Annuals > 0 > cash Flow > net Change In Cash
2072883
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.05610722532785897
Annuals > 0 > ratios > PB
72.52078113724475
Annuals > 0 > ratios > ROE
13.802373840636825
Annuals > 0 > ratios > ROA
12.540265759296268
Annuals > 0 > ratios > FCF
2080387
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.25416614437909846
Annuals > 0 > health Score
81
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6711990
Annuals > 1 > income Statement > cost Of Revenue
3351121
Annuals > 1 > income Statement > gross Profit
3360869
Annuals > 1 > income Statement > operating Expenses
1399940
Annuals > 1 > income Statement > operating Income
1960929
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
2253709
Annuals > 1 > income Statement > net Income
2253709
Annuals > 1 > income Statement > eps
0.012001705165127297
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
187782400
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
2266746
Annuals > 1 > income Statement > operating Margin
29.215314683126763
Annuals > 1 > income Statement > total Other Income Expense Net
292780
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
9687976
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
1884960
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
15749631
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
15811768
Annuals > 1 > balance Sheet > payables
827151
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
993060
Annuals > 1 > balance Sheet > equity
14818708
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
2253709
Annuals > 1 > cash Flow > depreciation
12059
Annuals > 1 > cash Flow > change In Working Capital
-1204013
Annuals > 1 > cash Flow > cash From Operations
898367
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
1730173
Annuals > 1 > cash Flow > cash From Financing
-42835
Annuals > 1 > cash Flow > net Change In Cash
2585705
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.012001705165127297
Annuals > 1 > ratios > PB
373.5700272925278
Annuals > 1 > ratios > ROE
15.208539098010435
Annuals > 1 > ratios > ROA
14.253364962096585
Annuals > 1 > ratios > FCF
898367
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.13384510406004776
Annuals > 1 > health Score
76
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
23544652
Annuals > 2 > income Statement > cost Of Revenue
10980847
Annuals > 2 > income Statement > gross Profit
12563805
Annuals > 2 > income Statement > operating Expenses
2368217
Annuals > 2 > income Statement > operating Income
10195588
Annuals > 2 > income Statement > interest Expense
7999
Annuals > 2 > income Statement > pretax Income
10011177
Annuals > 2 > income Statement > net Income
10011177
Annuals > 2 > income Statement > eps
0.06957462999822088
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
143891200
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
10025428
Annuals > 2 > income Statement > operating Margin
43.30320108362613
Annuals > 2 > income Statement > total Other Income Expense Net
-184411
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
7102271
Annuals > 2 > balance Sheet > short Term Investments
1566785
Annuals > 2 > balance Sheet > receivables
3581
Annuals > 2 > balance Sheet > inventories
353872
Annuals > 2 > balance Sheet > total Current Assets
13943227
Annuals > 2 > balance Sheet > property Plant Equipment
12059
Annuals > 2 > balance Sheet > total Assets
13958275
Annuals > 2 > balance Sheet > payables
1408042
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1411285
Annuals > 2 > balance Sheet > equity
12546990
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
10011177
Annuals > 2 > cash Flow > depreciation
6252
Annuals > 2 > cash Flow > change In Working Capital
-5529698
Annuals > 2 > cash Flow > cash From Operations
4448846
Annuals > 2 > cash Flow > capital Expenditures
2.88
Annuals > 2 > cash Flow > cash From Investing
-1527900
Annuals > 2 > cash Flow > cash From Financing
0
Annuals > 2 > cash Flow > net Change In Cash
2920946
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.06957462999822088
Annuals > 2 > ratios > PB
338.08208789518443
Annuals > 2 > ratios > ROE
79.78947141904153
Annuals > 2 > ratios > ROA
71.72216480904696
Annuals > 2 > ratios > FCF
4448843.12
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.1889534455637739
Annuals > 2 > health Score
85
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4428473
Annuals > 3 > income Statement > cost Of Revenue
1886500
Annuals > 3 > income Statement > gross Profit
2541973
Annuals > 3 > income Statement > operating Expenses
86095
Annuals > 3 > income Statement > operating Income
2455878
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
2535813
Annuals > 3 > income Statement > net Income
2535813
Annuals > 3 > income Statement > eps
0.02535813
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
100000000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
2535813
Annuals > 3 > income Statement > operating Margin
55.45654224379374
Annuals > 3 > income Statement > total Other Income Expense Net
79935
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4181325
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
717500
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
4915679
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
4915679
Annuals > 3 > balance Sheet > payables
1889866
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2379866
Annuals > 3 > balance Sheet > equity
2535813
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
2535813
Annuals > 3 > cash Flow > depreciation
0
Annuals > 3 > cash Flow > change In Working Capital
1645512
Annuals > 3 > cash Flow > cash From Operations
4181325
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
4181325
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.02535813
Annuals > 3 > ratios > PB
1162.5462918598494
Annuals > 3 > ratios > ROE
100
Annuals > 3 > ratios > ROA
51.58622033700736
Annuals > 3 > ratios > FCF
4181325
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.9441911467000025
Annuals > 3 > health Score
82
Valuation > metrics > PE
491.3333
Valuation > metrics > PB
47.4892819774154
Valuation > final Score
1
Valuation > verdict
1674.2% Overvalued
Profitability > metrics > ROE
12.826684708073774
Profitability > metrics > ROA
12.765922611010142
Profitability > metrics > Net Margin
0.8283981434198389
Profitability > final Score
86
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.004759679669164182
Risk > metrics > Interest Coverage
919420
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
458.673155376124
Liquidity > metrics > Quick Ratio
458.673155376124
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
0
Prev Profitabilities > 1
100
Prev Profitabilities > 2
56
Prev Risks > 0
-1735195
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:17:40.636Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-04-28
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.03
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.03
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-12-31
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.09
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.09
Earnings History > 1 > surprise Percent
-
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATrading Recap: Why is My Size Inc stock going up - Market Growth Summary & Intraday High Probability Setup Alerts baoquankhu1.vn
Read more →Investment Recap: Can OptimizeRx Corporation weather a recession - Quarterly Trade Review & Weekly Setup with ROI Potential baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Anbio Biotechnology Class A Ordinary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.03
EPS Estimate
0
EPS Difference
-0.03
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.